Department of Health Systems and Population Health, School of Public Health, University of Washington, Seattle, WA, United States of America; Department of Clinical Research and Leadership, School of Medicine and Health Sciences, The George Washington University, Washington, D.C., United States of America.
Department of Health Systems and Population Health, School of Public Health, University of Washington, Seattle, WA, United States of America.
J Subst Use Addict Treat. 2024 Oct;165:209456. doi: 10.1016/j.josat.2024.209456. Epub 2024 Jul 25.
Engagement is a critical component of successful treatment for opioid use disorder (OUD). However, rates of patient engagement in OUD treatment, especially in outpatient settings, are variable and often low. Little is known about the specific strategies members of primary care teams use to initiate and encourage ongoing participation in OUD treatment. In a national cohort of primary care clinics in the U.S., we explored the perspectives of primary care team members on the meaning of and approaches to OUD treatment engagement.
We conducted semi-structured interviews with 35 providers from multidisciplinary primary care teams in an existing national cohort of 13 clinics across seven states. Teams were delivering OUD treatment via the Collaborative Care Model, a model that combines primary care providers (PCP), behavioral health care managers (BHCM) and consulting psychiatric providers (CPP) in a structured way to provide patient-centered, team-based, and measurement-based care. Interview participants included 14 PCPs, 13 BHCMs, and 8 CPPs. Interviews asked open-ended questions about provider experiences and practices that aided or hindered patient engagement in OUD treatment. Interview transcripts were double-coded by trained qualitative researchers and analyzed using a combination of deductive and inductive approaches to identify themes.
Two themes emerged that describe provider perspectives on the meaning of engagement: 1) qualifying engagement by the volume of contact with patients, and 2) the need for more multidimensional measures of engagement. Six themes emerged that characterized provider engagement practices: 1) creating an environment of disclosure, 2) normalizing OUD treatment, 3) offering gentle but persistent outreach, 4) providing human connection and encouragement, 5) tailoring treatment to patient needs, and 6) avoiding stigmatizing responses. Analysis identified multiple replicable strategies that providers used to support these engagement practices.
Providers consistently apply a range of strategies when trying to engage patients in OUD treatment. Specific engagement strategies used embodied compassion and pragmatism, hallmarks of patient-centered care. Further research is needed to understand the impact of scaling engagement approaches across all care settings.
参与是阿片类药物使用障碍(OUD)成功治疗的关键组成部分。然而,OUD 治疗中患者的参与率,尤其是在门诊环境中,变化不定且往往较低。对于初级保健团队成员使用哪些具体策略来启动和鼓励持续参与 OUD 治疗,人们知之甚少。在美国的一个全国性初级保健诊所队列中,我们探讨了初级保健团队成员对 OUD 治疗参与的意义和方法的看法。
我们对来自七个州的 13 个诊所的现有全国性队列中的 35 名多学科初级保健团队成员进行了半结构化访谈。这些团队正在通过协作护理模式提供 OUD 治疗,该模式以结构化的方式将初级保健提供者(PCP)、行为健康护理经理(BHCM)和咨询精神科提供者(CPP)结合在一起,为患者提供以团队为中心、以测量为基础的护理。访谈参与者包括 14 名 PCP、13 名 BHCM 和 8 名 CPP。访谈问题涉及提供者在促进或阻碍 OUD 治疗患者参与方面的经验和实践。访谈记录由经过培训的定性研究人员进行双重编码,并采用演绎和归纳相结合的方法进行分析,以确定主题。
有两个主题出现,描述了提供者对参与意义的看法:1)通过与患者的接触量来确定参与程度,2)需要更全面的多维参与措施。出现了六个主题,描述了提供者的参与实践:1)营造披露环境,2)使 OUD 治疗正常化,3)提供温和但持续的拓展,4)提供人际联系和鼓励,5)根据患者需求调整治疗,6)避免污名化反应。分析确定了提供者用于支持这些参与实践的多种可复制策略。
提供者在尝试让患者参与 OUD 治疗时,始终会应用一系列策略。所使用的特定参与策略体现了关怀和务实精神,这是以患者为中心的护理的标志。需要进一步研究,以了解在所有护理环境中扩大参与方法的影响。